Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

22
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

15
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
15
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

411
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
411
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

31
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: Barresi et al: Surgical and observational outcomes in optic pit maculopathy: a comparative analysis of pediatric and adult populations(Ophthalmol Retina. 2026;10:445-454).

Ophthalmology. Retina·2026
Same author

Correspondence.

Retina (Philadelphia, Pa.)·2026
Same author

Hypertensive retinopathy: The need for a change in perspective.

Indian journal of ophthalmology·2025
Same author

Papillomacular bundle defects in optic disc pit maculopathy.

Eye (London, England)·2025
Same author

OPTIC PITLIKE MACULOPATHY WITH CLINICALLY OCCULT OPTIC DISK PIT DIAGNOSTIC IMAGING, CLINICAL FEATURES, AND MANAGEMENT.

Retina (Philadelphia, Pa.)·2025
Same author

Navigating Cardiovascular Challenges of Obesity: Exploring Preventive Approaches.

Endocrine, metabolic & immune disorders drug targets·2025

Related Experiment Video

Updated: Aug 10, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

295

Advanced Coats' disease: Treating the effect before the cause.

Dhananjay Shukla1

  • 1Retina-Vitreous Service, Ratan Jyoti Netralaya, Gwalior, Madhya Pradesh, India.

Oman Journal of Ophthalmology
|February 10, 2023
PubMed
Summary

This study details a successful multi-modal treatment approach for Coats' disease in a child, achieving significant vision recovery. The combined therapies effectively resolved retinal exudates and telangiectasia, preserving visual acuity.

Keywords:
BevacizumabCoats' diseasepharmacotherapyphotocoagulationscleral bucklingtriamcinolone acetonidevitrectomy

More Related Videos

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.1K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Related Experiment Videos

Last Updated: Aug 10, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

295
Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.1K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology

Background:

  • Coats' disease is a rare idiopathic retinal vascular disorder.
  • Stage 3A Coats' disease involves exudative retinal detachment and telangiectasia.

Observation:

  • An 8-year-old presented with Stage 3A Coats' disease and severe submacular lipid exudation.
  • Initial treatment included intravitreal bevacizumab and triamcinolone.

Findings:

  • A comprehensive treatment strategy involving scleral buckling, cryotherapy, subretinal fluid drainage, and photocoagulation was employed.
  • This led to near-total resolution of submacular exudates and regression of peripheral telangiectasia and exudative detachment.
  • Excellent visual acuity was sustained without macular fibrosis.

Implications:

  • Multi-modal treatment is effective for advanced Coats' disease in children.
  • Aggressive management can lead to favorable visual outcomes and prevent long-term complications.
  • This case highlights the importance of tailored therapeutic approaches for pediatric retinal vascular diseases.